Back to top
more

908 Devices (MASS)

(Delayed Data from NSDQ)

$5.67 USD

5.67
124,453

+0.11 (1.98%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $5.67 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates

Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 7.14% and 1.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 70% and 0.22%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Inc. (MASS) Upgraded to Buy: What Does It Mean for the Stock?

908 Devices Inc. (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

How Much Upside is Left in 908 Devices Inc. (MASS)? Wall Street Analysts Think 100.39%

The consensus price target hints at a 100.4% upside potential for 908 Devices Inc. (MASS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 12.12% and 16.74%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Shockwave Medical (SWAV) Misses Q2 Earnings Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -12.64% and 3.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Mesa Labs (MLAB) Surpasses Q1 Earnings Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 5.99% and 2.32%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Avinger (AVGR) Reports Q2 Loss, Misses Revenue Estimates

Avinger (AVGR) delivered earnings and revenue surprises of -20.41% and 11.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Inc. (MASS) Soars 8.5%: Is Further Upside Left in the Stock?

908 Devices Inc. (MASS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -11.43% and 9.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 21.43% and 6.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Masimo (MASI) Q4 Earnings and Revenues Beat Estimates

Masimo (MASI) delivered earnings and revenue surprises of 12.82% and 2.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ViewRay (VRAY) Reports Q4 Loss, Misses Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of 6.25% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical (GMED) Tops Q4 Earnings Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 7.27% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 9.09% and 0.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Q1 Loss, Tops Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of 33.33% and 2.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -10% and 4.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of 37.50% and 35.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Misses Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -800% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of -200% and 1.99%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (ATEC) Soars 7%: Is Further Upside Left in the Stock?

Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 2.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Miss Estimates

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -1.72% and 2.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?